Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v6.9)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-17

Query Trace: Hypertension and CYP2D6[original query]

Influence of CYP2D6 Polymorphism on the Pharmacokinetic/Pharmacodynamic Characteristics of Carvedilol in Healthy Korean Volunteers. Journal of Korean medical science 2018 Jul 33 (27): e182. Jung Eben, Ryu Sunae, Park Zewon, Lee Jong-Gu, Yi Jung-Yeon, Seo Doo Won, Lee Juhyun, Jeong Ho-Sang, Kim Jeong Mi, Oh Woo-Yo Similar articles in PubMed
The Association of ADRB1 and CYP2D6 Polymorphisms With Antihypertensive Effects and Analysis of Their Contribution to Hypertension Risk. The American journal of the medical sciences 2018 Mar 355 (3): 235-239. Chen Liping, Xiao Ting, Chen Liling, Xie Shanshan, Deng Maoqing, Wu Dingcha Similar articles in PubMed
Polymorphisms in CYP450 Genes and the Therapeutic Effect of Atorvastatin on Ischemic Stroke: A Retrospective Cohort Study in Chinese Population. Clinical therapeutics 2018 Feb . Peng Chen, Ding Ying, Yi Xin, Shen Yupei, Dong Zhiqiang, Cao Limei, Li Qiang, Ren Haiyan, He Lin, Zhou Daizhan, Chen Similar articles in PubMed
Multiple adverse drug reactions and genetic polymorphism testing: A case report with negative result. Medicine 2017 Nov 96 (45): e8505. Arellano Ana Lucía, Martin-Subero Marta, Monerris Mar, LLerena Adrián, Farré Magí, Montané E Similar articles in PubMed
OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS. Journal of hypertension 2016 Sep 34 Suppl 1 - ISH 2016 Abstract Book e388. Zeng Weiwei, Chu Tanya, Hu Miao, Kong Alice, Tomlinson Bri Similar articles in PubMed
Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to ?-blocker therapy in hypertension. The Journal of international medical research 2015 Jun 43 (3): 424-34. Wu Dingchang, Li Ganyang, Deng Maoqing, Song Wei, Huang Xiaohua, Guo Xiaoru, Wu Zhengzheng, Wu Shiyang, Xu Jias Similar articles in PubMed
Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate. Clinical pharmacology and therapeutics 2014 Aug 96 (2): 175-81. Hamadeh I S, Langaee T Y, Dwivedi R, Garcia S, Burkley B M, Skaar T C, Chapman A B, Gums J G, Turner S T, Gong Y, Cooper-DeHoff R M, Johnson J Similar articles in PubMed
Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations. Journal of clinical pharmacy and therapeutics 2012 Jun 37 (3): 364-9. Yin S-J, Ni Y-B, Wang S-M, Wang X, Lou Y-Q, Zhang G Similar articles in PubMed
Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics. Pharmacogenomics 2011 Jun 12 (6): 783-95. Sehrt Daniel, Meineke Ingolf, Tzvetkov Mladen, Gültepe Senol, Brockmöller Jürg Similar articles in PubMed
Effects of commonly administered agents and genetics on nebivolol pharmacokinetics: drug-drug interaction studies. Journal of clinical pharmacology 2011 Apr 51 (4): 575-85. Lindamood Charles, Ortiz Stephan, Shaw Andrew, Rackley Russ, Gorski J Christoph Similar articles in PubMed
[Efficacy and safety of bisoprolol in pregnant women with chronic arterial hypertension do not depend on genetic CYP2D6 polymorphism]. Kardiologiia 2009 49 (7-8): 50-5. Brytkova Ia V, Ignat'ev I V, Kazakov R E, Sokova E A, Striuk R Similar articles in PubMed
[Genetic aspects of individual sensitivity to betaxolol in patients with arterial hypertension]. Kardiologiia 2008 48 (3): 20-6. Minushkina L O, Zate?shchikova A A, Zate?shchikov D A, Mankhaeva B B, Savel'eva E G, Kochkina M S, Brovkin A V, Nikitin A G, Nosikov V V, Sidorenko B Similar articles in PubMed
Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension. Fundamental & clinical pharmacology 2007 Aug 21 (4): 437-43. Zateyshchikov Dmitry A, Minushkina Larissa O, Brovkin Alexey N, Savel'eva Ekaterina G, Zateyshchikova Anna A, Manchaeva Baira B, Nikitin Alexey G, Sidorenko Boris A, Nosikov Valery Similar articles in PubMed
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study. Clinical pharmacology and therapeutics 2005 Oct 78 (4): 378-87. Fux Richard, Mörike Klaus, Pröhmer Anne M T, Delabar Ursula, Schwab Matthias, Schaeffeler Elke, Lorenz Gernot, Gleiter Christoph H, Eichelbaum Michel, Kivistö Kari Similar articles in PubMed
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension. Clinical pharmacology and therapeutics 2004 Dec 76 (6): 536-44. Zineh Issam, Beitelshees Amber L, Gaedigk Andrea, Walker Joseph R, Pauly Daniel F, Eberst Kathleen, Leeder J Steven, Phillips Michael S, Gelfand Craig A, Johnson Julie Similar articles in PubMed
Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics. Clinical pharmacology and therapeutics 2004 Oct 76 (4): 302-12. Kirchheiner Julia, Heesch Claudia, Bauer Steffen, Meisel Christian, Seringer Angela, Goldammer Mark, Tzvetkov Mladen, Meineke Ingolf, Roots Ivar, Brockmöller Jürg Similar articles in PubMed
Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol. The Journal of international medical research 0 36 (6): 1354-62. Yuan H, Huang Z, Yang G, Lv H, Sang H, Yao Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Oct 1, 2020
Page last updated:Jan 19, 2021
Content source:

TOP